(Q33571804)

English

The economics of orphan drug policy in the US. Can the legislation be improved?

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

1 reference

Europe PubMed Central

The economics of orphan drug policy in the US. Can the legislation be improved? (English)

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

1 reference

based on heuristic

inferred from title

author name string

Peabody JW

1

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Ruby A

2

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Cannon P

3

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

publication date

1 November 1995

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

PharmacoEconomics

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

374-384

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Patents in the public interest

1 reference

https://pubmed.ncbi.nlm.nih.gov/10160072

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The use--and misuse--of growth hormone

1 reference

https://pubmed.ncbi.nlm.nih.gov/10160072

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A closer look at the returns and risk of pharmaceutical R&D

1 reference

https://pubmed.ncbi.nlm.nih.gov/10160072

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Knocking on opportunity's window

1 reference

https://pubmed.ncbi.nlm.nih.gov/10160072

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Back to the future: biotech product sales 1983-1993.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10160072

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Does selegiline monotherapy in Parkinson's disease act by symptomatic or protective mechanisms?

1 reference

https://pubmed.ncbi.nlm.nih.gov/10160072

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cost of innovation in the pharmaceutical industry

1 reference

https://pubmed.ncbi.nlm.nih.gov/10160072

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The Orphan Drug Act. The first 7 years

1 reference

https://pubmed.ncbi.nlm.nih.gov/10160072

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Orphan products: origins, progress, and prospects

1 reference

https://pubmed.ncbi.nlm.nih.gov/10160072

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2165/00019053-199508050-00002

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33571804&oldid=2195504414"